IP Library Granted Patent US 9,012,581
Granted Patent B2
US 9,012,581 · App. 12/861,454 · Granted Apr 21, 2015

Ophthalmic and otorhinolaryngological device materials

Inventor: Walter R. Laredo (Fort Worth, TX)
Assignee: Novartis AG
G02B1/043C08F2222/145C08F2222/205C08L33/08C08L33/10C08L33/12C08F220/16C08F220/26C08F222/1006C08F290/062Y10S525/937Y10S525/91
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,012,581
App. No.
12/861,454
Granted
Apr 21, 2015
Kind
B2
Abstract

Disclosed are soft, high refractive index, acrylic device materials. The materials contain a copolymeric additive for glistening resistance.

Claims (78)

1. A polymeric ophthalmic or otorhinolaryngological device material comprising

a) 70 to 98% (w/w) of a monofunctional monomer of formula [1]:

wherein

B═—O(CH 2 ) n —, —(OCH 2 CH 2 ) n —, —NH(CH 2 ) n —, or —NCH 3 (CH 2 ) n —;

R 1 ═H, CH 3 , CH 2 CH 3 , or CH 2 OH;

n=0-12;

A=C 6 H 5 or O(CH 2 ) m C 6 H 5 , where the C 6 H 5 group is optionally substituted with —(CH 2 ) n H, —O(CH 2 ) n H, —CH(CH 3 ) 2 , —C 6 H 5 , —OC 6 H 5 , —CH 2 C 6 H 5 , F, Cl, Br, or I; and

m=0-18;

b) a difunctional cross-linking monomer of formula [2]:

wherein

R 2 , R 3 independently=H, CH 3 , CH 2 CH 3 , or CH 2 OH;

W, W′ independently=O(CH 2 ) d , NH(CH 2 ) d , NCH 3 (CH 2 ) d , O(CH 2 ) d C 6 H 4 , O(CH 2 CH 2 O) d CH 2 , O(CH 2 CH 2 CH 2 O) d CH 2 , O(CH 2 CH 2 CH 2 CH 2 O) d CH 2 , or nothing;

J=(CH 2 ) a , O(CH 2 CH 2 O) b , O, or nothing, provided that if W and W′=nothing, then J ≠ nothing;

d=0-12;

a=1-12; and

b=1-24;

and

c) 0.5 to 15% (w/w) of a copolymer additive of formula [3]:

wherein for formula [3]:

D=OCH 2 CH 2 S, SCH 2 C═O, CH 3 CH(OH)CH 2 S, SCH 2 CH(OH)CH 2 O, S(CH 2 ) 11 O, S(CH 2 ) 10 C═O, S(CH 2 ) 14 C═O, S(CH 2 ) 15 C═O, SC 6 H 4 CH 2 O, CH 3 CH(S)C═O, S(CH 2 CH 2 CH 2 )O, CH 3 CH(S)CH(O)CH 3 , OCH 2 CH 2 C(CH 3 ) 2 S, SCH 2 CH 2 C═O, S(CH 2 ) 4 O, SC 6 H 4 CH 2 C═O, SC 6 H 4 C═O, S(CH 2 ) 11 C═O, CH 3 CH(O)CH(S)CH 3 , SC 6 H 4 C═O, S(CH 2 ) 6 OC 6 H 4 CH 2 O, S(CH 2 ) 6 O, S(CH 2 ) 5 C═O, S(CH 2 ) 7 C═O, S(CH 2 ) 9 O, C(CH 3 ) 2 C(═O)NHCH 2 CH 2 O, C(CH 3 ) 2 C(═NH)NHCH 2 CH 2 C═O, C(CH 3 ) 2 C(═O)NHCH(CH 2 CH 3 )(CH 2 O), C(CH 3 ) 2 CN, C(CH 3 )(CN)CH 2 C(OCH 3 )(CH 3 CH 3 ) , C(CH 3 ) 2 C(═O)NHCH 2 CH═CH 2 , C(CH 3 )(CN)CH 2 C(CH 3 ) 2 (OCH 3 ), C(CH 3 )(CN)CH 2 CH(CH 3 ) 2 , C(CH 3 ) 2 C(═O)OCH 3 , C(CH 3 )(CN)CH 2 CH 3 , C(CN)(CH 2 ) 5 , C(CH 3 ) 2 C(═O)NHCH 2 CH 2 CH 2 CH 3 , or C(CH 3 ) 2 C(═O)NHC 6 H 11 ;

E=nothing, O(CH 2 ) n NH, (OCH 2 CH 2 ) n NH, O(CH 2 ) n NHC═O, HN(CH 2 ) n NH, OH, or H; provided that if D=C(CH 3 ) 2 CN, C(CH 3 )(CN)CH 2 C(OCH 3 )(CH 3 CH 3 ), C(CH 3 ) 2 C(═O)NHCH 2 CH═CH 2 , C(CH 3 )(CN)CH 2 C(CH 3 ) 2 (OCH 3 ), C(CH 3 )(CN)CH 2 CH(CH 3 ) 2 , C(CH 3 ) 2 C(═O)OCH 3 , C(CH 3 )(CN)CH 2 CH 3 , C(CN)(CH 2 ) 5 , C(CH 3 ) 2 C(═O)NHCH 2 CH 2 CH 2 CH 3 , or C(CH 3 ) 2 C(═O)NHC 6 H 11 , then E=F=nothing;

n=1-5;

if D≠C(CH 3 ) 2 CN, C(CH 3 )(CN)CH 2 C(OCH 3 )(CH 3 CH 3 ), C(CH 3 ) 2 C(═O)NHCH 2 CH═H 2 , C(CH 3 )(CN)CH 2 C(CH 3 ) 2 (OCH 3 ), C(CH 3 )(CN)CH 2 CH(CH 3 ) 2 , C(CH 3 ) 2 C(O)OCH 3 , C(CH 3 )(CH)CH 2 CH 3 , C(CN)(CH 2 ) 5 , C(CH 3 ) 2 C(═O)NHCH 2 CH 2 CH 2 CH 3 , or C(CH 3 ) 2 C(O)NHC 6 H 11 then

if E=H or OH, then F=nothing;

if E≠H or OH, then F═C(═O)C(CH 3 )═CH 2 , C(═O)CH═CH 2 , C(═O)C(CH 2 CH 3 )═CH 2 , C(═O)C(CH 2 OH)═CH 2 , C(═O)NHCH 2 CH 2 OC(═O)C(CH 3 )═CH 2 , or C(═O)NHC(CH 3 ) 2 C 6 H 4 C(═CH 2 )CH 3 ;

R 4 , R 5 , and R 6 independently=H or CH 3 ;

t, u, and v represent molar fraction values and t+u+v=1;

t and u independently=0-0.95; provided that t+u=0.8-0.95;

v=0.05-0.2;

W═H, CH 3 , C(═O)C(CH 3 )═CH 2 , C(═O)CH═CH 2 , C(═O)C(CH 2 CH 3 )═CH 2 , C(═O)C(CH 2 OH)═CH 2 , C(═O)NHCH 2 CH 2 OC(═O)C(CH 3 )═CH 2 , or C(═O)NHC(CH 3 ) 2 C 6 H 4 C(═CH 2 )CH 3 ; provided that if F=nothing, then W═C(═O)C(CH 3 )═CH 2 , C(═O)CH═CH 2 , C(═O)C(CH 2 CH 3 )═CH 2 , C(═O)C(CH 2 OH)═CH 2 , C(═O)NHCH 2 CH 2 OC(═O)C(CH 3 )═CH 2 , or C(═O)NHC(CH 3 ) 2 C 6 H 4 C(═CH 2 )CH 3 ;

y 1 , y 2 , and y 3 independently=4-200; and

x=1-100;

wherein the polymeric device material has an equilibrium water content of 0.5-3.0%.

2. The polymeric device material of claim 1 wherein for the monomer of formula [I]:

B═—O(CH 2 ) n — or —(OCH 2 CH 2 ) n —;

R 1 ═—H or —CH 3 ;

n=1-5;

A=—C 6 H 5 , O(CH 2 ) m C 6 H 5 ; and

m=0-4.

3. The polymeric device material of claim 1 wherein for the monomer of formula [2]:

R 2 , R 3 independently=H or CH 3 ;

W, W′ independently=O(CH 2 ) d , O(CH 2 ) d C 6 H 4 , or nothing;

J=O(CH 2 CH 2 O) b or nothing, provided that if W and W′=nothing, then J≠nothing;

d=0-6; and

b=1-10.

4. The polymeric device material of claim 1 wherein the copolymer additive of formula [3] has a number average molecular weight (M n ) from 3,000 to 10,000 Daltons.

5. The polymeric device material of claim 1 wherein for the copolymer additive of formula [3]:

D=OCH2CH2S or OCH2CH2CH2S;

E=nothing, H, or OH;

if E=H or OH, then F=nothing;

if E≠H or OH, then F═C(═O)C(CH3)=CH2;

R4=R5=R6=CH3;

W═C(═O)C(CH3)=CH2;

t and u independently=0-0.95; provided that t+u=0.85-0.95;

v=0.05-0.15;

y1, y2, and y3 independently=4-20; and

x=5-50.

6. The polymeric device material of claim 5 wherein for the copolymer additive of formula [3]:

D=OCH2CH2S;

E=nothing;

F═C(═O)C(CH3)=CH2;

R4=R5=R6=CH3;

W═C(═O)C(CH3)=CH2;

t and u independently=0-0.9; provided that t+u=0.85-0.9;

v=0.1-0.15;

y=4-20; and

x=5-50.

7. The polymeric device material of claim 1 wherein the monomer of formula [1] is selected from the group consisting of benzyl methacrylate; 2-phenylethyl methacrylate; 3-phenylpropyl methacrylate; 4-phenylbutyl methacrylate; 5-phenylpentyl methacrylate; 2-phenoxyethyl methacrylate; 2-(2-phenoxyethoxy)ethyl methacrylate; 2-benzyloxyethyl methacrylate; 2-(2-(benzyloxy)ethoxy)ethyl methacrylate; 3-benzyloxypropyl methacrylate; benzyl acrylate; 2-phenylethyl acrylate; 3-phenylpropyl acrylate; 4-phenylbutyl acrylate; 5-phenylpentyl acrylate; 2-phenoxyethyl acrylate; 2-(2-phenoxyethoxy)ethyl acrylate; 2-benzyloxyethyl acrylate; 2-(2-(benzyloxy)ethoxy)ethyl acrylate; and 3-benzyloxypropyl acrylate.

8. The polymeric device material of claim 1 wherein the monomer of formula [2] is selected from the group consisting of ethylene glycol dimethacrylate; diethylene glycol dimethacrylate; triethylene glycol dimethacrylate; 1,6-hexanediol dimethacrylate; 1,4-butanediol dimethacrylate; 1,4-benzenedimethanol dimethacrylate; ethylene glycol diacrylate; diethylene glycol diacrylate; triethylene glycol diacrylate; 1,6-hexanediol diacrylate; 1,4-butanediol diacrylate; and 1,4-benzenedimethanol diacrylate.

9. The polymeric device material of claim 1 wherein the amount of monomer [1] is 80 to 95% (w/w).

10. The polymeric device material of claim 1 wherein the amount of monomer [2] is 0.5 to 3% (w/w).

11. The polymeric device material of claim 1 wherein the amount of copolymer additive [3] is 1 to 10% (w/w).

12. The polymeric device material of claim 11 wherein the amount of copolymer additive [3] is 1 to 5% (w/w).

13. The polymeric device material of claim 12 wherein the amount of copolymer additive [3] is 2 to 4% (w/w).

14. The polymeric device material of claim 1 further comprising an ingredient selected from the group consisting of a polymerizable UV absorbers and a polymerizable colorants.

15. The polymeric device material of claim 14 comprising 0.1-5% (w/w) of a polymerizable UV absorber and 0.01-0.5% (w/w) of a polymerizable colorant.

16. An ophthalmic or otorhinolaryngological device comprising the polymeric device material of claim 1 wherein the ophthalmic or otorhinolaryngological device is selected from the group consisting of intraocular lenses; contact lenses; keratoprostheses; corneal inlays or rings; otological ventilation tubes; and nasal implants.

17. The ophthalmic or otorhinolaryngological device of claim 16 wherein the ophthalmic or otorhinolaryngological device is an intraocular lens.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2010
From: LAREDO, WALTER R.
To: ALCON, INC.
Reel/Frame 024872/0831 →
Continuity (2)
Provisional Application 61236402 · Aug 24, 2009
Related Publication 20110046258A1 · Feb 24, 2011